Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
- PMID: 26291035
- PMCID: PMC4550137
- DOI: 10.3201/eid2109.150508
Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States
Abstract
The Healthcare-Associated Infections Community Interface (HAIC), launched in 2009, is the newest major activity of the Emerging Infections Program. The HAIC activity addresses population- and laboratory-based surveillance for Clostridium difficile infections, candidemia, and multidrug-resistant gram-negative bacilli. Other activities include special projects: the multistate Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey and projects that evaluate new approaches for improving surveillance. The HAIC activity has provided information about the epidemiology and adverse health outcomes of health care-associated infections and antimicrobial drug use in the United States and informs efforts to improve patient safety through prevention of these infections.
Keywords: Candida; Clostridium difficile; EIP; Emerging Infections Program; MRSA; United States; antimicrobial resistance; bacteria; candidemia; enteric infections; epidemiology; health care; methicillin-resistant Staphylococcus aureus; multidrug-resistant gram-negative bacilli; nosocomial infections; surveillance.
References
-
- Centers for Disease Control and Prevention. Winnable battles—healthcare-associated infections [cited 2015 Mar 2]. http://www.cdc.gov/winnablebattles/healthcareassociatedinfections/index....
-
- Centers for Disease Control and Prevention. Emerging Infections Program—healthcare-associated infections projects. [cited 2015 Mar 2]. http://www.cdc.gov/hai/eip/index.html
-
- Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998–2000 in a population-based active surveillance program. J Clin Microbiol. 2004;42:1519–27. 10.1128/JCM.42.4.1519-1527.2004 - DOI - PMC - PubMed
-
- Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011. Clin Infect Dis. 2012;55:1352–61. 10.1093/cid/cis697 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
